Chronic Kidney Disease Trial, Recruiting NCT01893710 Sponsor: Heidelberg University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT01893710
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 0 to 90 years old
  • People with advanced kidney disease (stage 5) who are on peritoneal dialysis (a type of dialysis done through the abdomen)
  • People with normal kidney function who are scheduled for planned abdominal surgery for a minor condition, such as a hernia repair or gallstone removal
  • People who have previously been on peritoneal dialysis or have had a kidney transplant
  • People who are able to give both verbal and written agreement to participate
  • Adult patients who can consent for themselves, or for patients under the legal age of adulthood, a parent or legal guardian who is able to give consent on their behalf

Who may not be able to join:

  • People who have abdominal scarring, abnormal structures, or inflammation in the abdomen that is not related to peritoneal dialysis
  • People who have cancer that has spread to multiple parts of the body
  • People with severe heart failure or other serious medical conditions where an additional procedure could increase health risks
  • People who are pregnant
  • Babies born before 37 weeks of pregnancy (premature babies)
  • Newborns with a blood haemoglobin level below 10 g/dl, or children and adults with a level below 8 g/dl (a measure of red blood cell levels that indicates anaemia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claus P Schmitt, MD, University of Heidelberg, Center for Pediatric and Adolescent Medicine

Phone: +49 6221 56

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Heidelberg University
Registry
ClinicalTrials.gov
Start date
1 February 2011
Est. completion
1 October 2028

Where this trial is recruiting

🇦🇹 Austria 🇧🇪 Belgium 🇨🇿 Czechia 🇫🇷 France 🇩🇪 Germany 🇭🇺 Hungary 🇮🇹 Italy 🇱🇹 Lithuania 🇲🇾 Malaysia 🇵🇱 Poland 🇪🇸 Spain 🇸🇪 Sweden 🇨🇭 Switzerland Turkey (Türkiye) 🇺🇸 United States

Primary endpoints

Peritoneal vasculopathy (lumen vessel ratio)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov